Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 19782-19791

  Liu, Jun Jie ^a   Chen, Yuan Yuan ^a   Mo, Zeng Nan ^a,b   Tian, Gui Xiang ^a   Tan, Ai Hua ^a   Gao, Yong ^b   Yang, Xiao Bo ^b   Zhang, Hai Ying ^b   Li, Zhi Xian ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Insulin resistance; Non alcoholic fatty liver disease; Osteocalin; Ultrasonography

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLIC FATTY LIVER; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND SCANNER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHINA; FATTY LIVER; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; YOUNG ADULT;

EID: 84885170188     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141019782     Document Type: Article

References (31)

1. Adams, L.A.; Angulo, P.; Lindor, K.D. Nonalcoholic fatty liver disease. CMAJ 2005, 172, 899-905.
2. Hou, X.H.; Zhu, Y.X.; Lu, H.J.; Chen, H.F.; Li, Q.; Jiang, S.; Xiang, K.S.; Jia, W.P. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J. Gastroenterol. Hepatol. 2011, 26, 722-730.
3. Fan, J.G.; Saibara, T.; Chitturi, S.; Kim, B.I.; Sung, J.J.; Chutaputti, A. Asia-Pacific Working Party for NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific. J. Gastroenterol. Hepatol. 2007, 22, 794-800.
4. Amarapurkar, D.N.; Hashimoto, E.; Lesmana, L.A.; Sollano, J.D.; Chen, P.J.; Goh, K.L. Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences. J. Gastroenterol. Hepatol. 2007, 22, 788-793.
5. Fan, J.G.; Farrell, G.C. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009, 50, 204-210.
6. McCullough, A.J. Pathophysiology of nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2006, 40, S17-S29.
7. Utzschneider, K.M.; Kahn, S.E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 2006, 91, 4753-4761.
8. Jornayvaz, F.R.; Samuel, V.T.; Shulman, G.I. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu. Rev. Nutr. 2010, 30, 273-290.
9. Lee, N.K.; Sowa, H.; Hinoi, E.; Ferron, M.; Ahn, J.D.; Confavreux, C.; Dacquin, R.; Mee, P.J.; McKee, M.D.; Jung, D.Y.; et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130, 456-469.
10. Ducy, P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 2011, 54, 1291-1297.
11. Pittas, A.G.; Harris, S.S.; Eliades, M.; Stark, P.; Dawson-Hughes, B. Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metab. 2009, 94, 827-832.
12. Tan, A.H.; Gao, Y.; Yang, X.B.; Zhang, H.Y.; Qin, X.; Mo, L.J.; Peng, T.; Xia, N.; Mo, Z.N. Low serum osteocalcin level is a potential marker for metabolic syndrome: Results from a Chinese male population survey. Metabolism 2011, 60, 1186-1192.
13. Fernández-Real, J.M.; Ortega, F.; Gómez-Ambrosi, J.; Salvador, J.; Frühbeck, G.; Ricart, W. Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss. Osteoporos. Int. 2010, 21, 2101-2107.
14. Dou, J.; Ma, X.; Fang, Q.; Hao, Y.; Yang, R.; Wang, F.; Zhu, J.; Bao, Y.; Jia, W. Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men. Clin. Exp. Pharmacol. Physiol. 2013, 40, 282-288.
15. Yilmaz, Y.; Kurt, R.; Eren, F.; Imeryuz, N. Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degeneration. Scand. J. Clin. Lab. Invest. 2011, 71, 631-636.
16. Yilmaz, Y. Review article: Non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Aliment. Pharmacol. Ther. 2012, 36, 345-352.
17. Saadeh, S.; Younossi, Z.M.; Remer, E.M.; Gramlich, T.; Ong, J.P.; Hurley, M.; Mullen, K.D.; Cooper, J.N.; Sheridan, M.J. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123, 745-750.
18. Aller, R.; Castrillon, J.L.; de Luis, D.A.; Conde, R.; Izaola, O.; Sagrado, M.G.; Velasco, M.C.; Alvarez, T.; Pacheco, D. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. Ann. Hepatol. 2011, 10, 50-55.
19. Cusi, K.; Chang, Z.; Harrison, S.; Lomonaco, R.; Bril, F.; Orsak, B.; Ortiz-Lopez, C.; Hecht, J.; Feldstein, A.E.; Webb, A.; et al. Limited Value of Plasma Cytokeratin-18 as a Biomarker for NASH and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease (NAFLD). J. Hepatol. 2013, doi:10.1016/j.jhep.2013.07.042.
20. Musso, G.; Bo, S.; Cassader, M.; de Michieli, F.; Gambino, R. Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism. Am. J. Clin. Nutr. 2013, 98, 895-906.
21. Adams, L.A.; Angulo, P. Treatment of non-alcoholic fatty liver disease. Postgrad. Med. J. 2006, 82, 315-322.
22. Yeap, B.B.; Chubb, S.A.P.; Flicker, L.; McCaul, K.A.; Ebeling, P.R.; Beilby, J.P.; Norman, P.E. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur. J. Endocrinol. 2010, 163, 265-272.
23. Saleem, U.; Mosley, T.H., Jr.; Kullo, I.J. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1474-1478.
24. Zhou, M.; Ma, X.; Li, H.; Pan, X.; Tang, J.; Gao, Y.; Hou, X.; Lu, H.; Bao, Y.; Jia, W. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur. J. Endocrinol. 2009, 161, 723-729.
25. Adams, L.A.; Talwalkar, J.A. Diagnostic evaluation of nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 2006, 40, S34-S38.
26. Mottin, C.C.; Moretto, M.; Padoin, A.V.; Swarowsky, A.M.; Toneto, M.G.; Glock, L.; Repetto, G. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes. Surg. 2004, 14, 635-637.
27. Joy, D.; Thava, V.R.; Scott, B.B. Diagnosis of fatty liver disease: Is biopsy necessary. Eur. J. Gastroenterol. Hepatol. 2003, 15, 539-543.
28. Sanyal, A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002, 123, 1705-1725.
29. Fan, J.G. Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: An updated and revised edition. Chin. J. Hepatol. 2010, 18, 163-166.
30. Meziri, M.; Pereira, W.C.; Abdelwahab, A.; Degott, C.; Laugier, P. In vitro chronic hepatic disease characterization with a multiparametric ultrasonic approach. Ultrasonics 2005, 43, 305-313.
31. Pulzi, F.B.; Cisternas, R.; Melo, M.R.; Ribeiro, C.M.; Malheiros, C.A.; Salles, J.E. New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol. Metab. Syndr. 2011, doi:10.1186/1758-5996-3-3.